MedTrace Logo

Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®

NCT03006965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-06-08

No results posted yet for this study

Summary

The purpose of this study is to describe the pharmacokinetic profile of patients with hemophilia A in prophylaxis in Spain using myPKFit®

Conditions

Interventions

DRUG

octocog alfa

Pharmacokinetic Characterization of the Hemophilia A Population in Spain using an standalone web-based software

DRUG

rurioctocog alfa pegol

Pharmacokinetic Characterization of the Hemophilia A Population in Spain using an standalone web-based software

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • Instituto de Investigación Hospital Universitario La Paz

    collaborator OTHER

  • Spanish Society of Thrombosis and Haemostasis

    lead OTHER

Principal Investigators

  • M Teresa Álvarez Román, MD,PhD · Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid

Eligibility

Min Age
1 Year
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-11
Primary Completion
2022-12-22
Completion
2022-12-22

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03006965 on ClinicalTrials.gov